NCT02056756View on ClinicalTrials.gov

Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

January 30, 2023

Conditions
Multiple Myeloma
Interventions
DRUG

Carfilzomib

Trial Locations (3)

10126

Fondazione EMN Italy Onlus, Torino

24105

Universitätsklinikum Schleswig-Holstein (UKSH) - Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, Kiel

60126

Divisione di Ematologia A.O.U. Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi di Ancona, Ancona

All Listed Sponsors
collaborator

Fondazione EMN Italy Onlus

OTHER

lead

Stichting European Myeloma Network

NETWORK

NCT02056756 - Carfilzomib In Combination With Bendamustine And Dexamethasone In Refractory Or Relapsed Multiple Myeloma | Biotech Hunter | Biotech Hunter